Lilly upgraded

|By:, SA News Editor

Cowen & Company upgrades Eli Lilly (LLY) to Outperform with a $68 PT. Yesterday's close was $59.15.

Consensus estimates for Q1 and Q2 are earnings of $0.70/share on revenues of $4.76B and $0.66/share on revenues of $4.85B, respectively.

Consensus views for 2014 and 2015 are earnings of $2.81/share on revenues of $19.7B and $3.18 on revenues of $20.2B, respectively.

1825 mutual funds have positions, down from 1967 a year earlier.